Related Experiment Video
Updated: Jun 23, 2026

Establishment of Coloproctitis Cancer Model in Mice and Evaluation of Therapeutic Effect of Chinese Medicine
Published on: October 13, 2023
Rationale for cancer prevention strategies in high-risk ulcerative colitis
1Centre for Cancer Research and Cell Biology, Lisburn Road, Queen's University of Belfast. f.c.campbell@qub.ac.uk
Detecting dysplasia in inflammatory bowel disease is challenging, leading to underdiagnosis and interval cancers. Understanding the link between inflammation and cancer aids decisions on surveillance and colectomy for ulcerative colitis and Crohn
Area of Science:
- Gastroenterology
- Oncology
- Colorectal Cancer Research
Background:
- Colorectal cancer (CRC) is a significant risk in ulcerative colitis (UC) and Crohn's colitis.
- Current surveillance relies on colonoscopy and biopsies to guide colectomy decisions.
- Difficulties in dysplasia detection can lead to underdiagnosis and interval cancers.
Purpose of the Study:
- To review current knowledge on inflammation and neoplastic transformation in colitis.
- To discuss clinical variables influencing cancer risk and treatment decisions.
- To provide guidance on surveillance and prophylactic colectomy indications.
Main Methods:
- Literature review of recent advancements in cancer biology and inflammatory bowel disease.
- Analysis of clinical variables: disease duration, severity, and anti-inflammatory therapy.
- Discussion of stepwise neoplastic transformation in colitis.
Main Results:
- Dysplasia detection in colitis is challenging, risking underdiagnosis.
- Inflammation and neoplastic changes are closely linked in CRC development.
- Interval cancers occur despite negative surveillance colonoscopies.
Conclusions:
- A better understanding of cancer biology is crucial for effective CRC prevention in IBD.
- Clinical variables and inflammation-neoplasia relationship inform surgical decisions.
- Clearer indications for surveillance and colectomy are needed for optimal patient management.
More Related Videos
09:01Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice
Published on: March 10, 2015
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Related Concept Videos
Cancer Prevention
Some...
Cancer Prevention
Some...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Drugs for Treatment of Ulcerative Colitis in IBD
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...